山奈酚市场（2026—2031）
山奈酚市场规模预计由2026年的45.1亿美元增至2031年的61.1亿美元，预测期复合年增长率为6.23%。北美是当前最大市场，亚太地区增长最快。
市场研究正文
规模、增长、细分、驱动因素与关键问题
当前质量分 100.00，审核状态 accepted。结构化字段已按 RoboInd 内容层级组织。
核心结论
山奈酚市场规模预计由2026年的45.1亿美元增至2031年的61.1亿美元，预测期复合年增长率为6.23%。北美是当前最大市场，亚太地区增长最快。
市场走势
结构化指标
| 指标 | 年份 | 数值 | 性质 |
|---|---|---|---|
| 复合年增长率 | 2031 | 6.23% | 机构预测 |
| 市场规模 | 2026 | USD 4.51 billion | 机构预测 |
| 市场规模 | 2031 | USD 6.11 billion | 机构预测 |
细分市场份额
市场结构
| 维度 | 细分项 | 年份 | 份额 |
|---|---|---|---|
| form | powder | 2025 | 53.120% |
| geography | North America | 2025 | 34.280% |
| purity | 98% purity | 2025 | 43.590% |
关键结论
- form 维度中，powder 在 2025 年的公开份额为 53.12%。
- geography 维度中，North America 在 2025 年的公开份额为 34.28%。
- purity 维度中，98% purity 在 2025 年的公开份额为 43.59%。
主要参与者
- Extrasynthese SAS
- Indena S.p.A.
- Merck KGaA
- Risun Bio‑Tech Co., Ltd.
- Shaanxi Huike Botanical Development Co., Ltd.
增长驱动因素
| 因素 | 影响 CAGR | 地区相关性 | 影响周期 |
|---|---|---|---|
| Expansion of Nutraceutical and Preventive-Wellness Formulations | +1.800% | Global | Medium term (2-4 years) |
| Demand for Natural Antioxidants in Functional Foods and Beverages | +1.400% | North America and EU | Medium term (2-4 years) |
| Pharmaceutical Research into Anti-Inflammatory and Anticancer Applications | +1.200% | Global | Long term (≥ 4 years) |
| Premiumization Toward High-Purity Botanical Ingredients | +0.900% | North America, EU, and Japan | Short term (≤ 2 years) |
| Glycoside-Enabled Formulation and Bioavailability Innovation | +0.700% | APAC core, with spillover to North America | Long term (≥ 4 years) |
| Botanical Upcycling and Low-Residue Extraction Economics | +0.500% | APAC core, with spillover to EU | Medium term (2-4 years) |
市场制约因素
| 因素 | 影响 CAGR | 地区相关性 | 影响周期 |
|---|---|---|---|
| Low Water Solubility and Oral Bioavailability | -0.800% | Global | Short term (≤ 2 years) |
| High Purification Cost at Pharmaceutical-Grade Assays | -0.700% | Global | Medium term (2-4 years) |
| Raw-Material Variability and Climate Exposure | -0.500% | APAC and South America | Short term (≤ 2 years) |
| Uneven Regulatory and Health-Claim Pathways Across Regions | -0.300% | Global | Long term (≥ 4 years) |
报告关注的关键问题
What is the forecast growth rate for kaempferol?
The kaempferol market is forecast to grow at a 6.23% CAGR from 2026 to 2031, reaching USD 6.11 billion by 2031.
Which kaempferol type leads demand?
Natural kaempferol led with 73.68% revenue share in 2025, supported by established botanical extraction and plant-derived product positioning.
Which application is growing fastest for kaempferol?
Pharmaceutical use is forecast to grow at a 7.21% CAGR through 2031 as clinical investigation and formulation research advance.
Why are encapsulated kaempferol formats gaining use?
Encapsulated and complexed formats are forecast to grow at an 8.25% CAGR because they address low water solubility and limited oral bioavailability.
Which region is growing fastest for kaempferol?
Asia-Pacific is forecast to grow at a 9.17% CAGR through 2031, supported by demand in China, Japan, and India.
市场概览
- 增长最快市场：亚太地区
- 最大市场：北美
- 市场集中度：低
查看来源：Mordor Intelligence